Australian veterinarians can now purchase our full range of products directly from Zoetis.
Zoetis Direct is a business-to-business initiative. Zoetis does not supply products directly to the general public.
VIDEO: OVERVIEW OF ZOETIS DIRECT
Zoetis Direct evolves the way we deliver value to you, your clinic and importantly to your patients. You will enjoy transparent pricing, a simple ordering system, seamless delivery and easy access to expert advice through our direct distribution commitment.
Glanvac® 6 B12 provides goats with protection against cheesy gland and the five main clostridial diseases with the added ability to correct cobalt deficiencies in goats and kids.
Goat producers are benefiting from the features of this vaccine. The prevention of cheesy gland in goat flocks improves fibre production and increases the quality of goat meat. Cobalt is an essential trace element which is important for the production of vitamin B12 in the rumen. Cobalt deficiency can severely affect energy production which results is reduced fibre and meat production.
Glanvac® 6 B12 utilises Zoetis' ultra-filtration technology, which selectively removes unwanted particles during the production process. This allows the vaccine to produce a more targeted immune response in goats, while providing producers with the convenience of a 1mL dose rate.
For the control of caseous lymphadenitis (cheesy gland); prevention of enterotoxaemia (pulpy kidney disease), prevention of tetanus, prevention of black disease, prevention of malignant oedema (blackleg-like disease), prevention of blackleg in goats and kids.
Treatment and prevention of vitamin B12 deficiency in goats, in areas of known or suspected cobalt deficiency.
Goats do not commonly suffer from clostridial diseases other than tetanus and enterotoxaemia. Use Glanvac® 3 unless these diseases are known to occur in goats on the property.
Inject 1mL subcutaneously on the side of the neck just behind and below the base of the ear.
In previously unvaccinated animals of all ages, give a 1mL dose and repeat 4 weeks later.
Goats require regular revaccination at 6 monthly intervals to maintain effective immunity against enterotoxaemia.
Where possible give booster doses prior to the time of maximum risk eg transfer to lush pasture or grain feeding in the case of enterotoxaemia.
Pregnant Doses: Give previously unvaccinated animals 1mL at the time of joining; repeat at up to 4 weeks before the expected time of kidding. Omit the dose at joining in previously vaccinated animals. Vaccinated does will pass on immunity to their kids in the colostrum: kids should be protected for the first 6 to 8 weeks of life.
This product can be stored and used for up to 30 days after first opening. On each subsequent reuse, swab the opening with a suitable disinfectant (for example, methylated spirits) both before and after using. A sterile needle must be used each time product is removed. Store unused material upright, at 2°C to 8°C (refrigerated) and in the original cardboard packaging to protect from light.
Storage Store at 2°C to 8°C (refrigerate. Do not freeze). Protect from light. Prolonged exposure to light will have an adverse effect on vitamin B12.
Withholding Period: NIL
Localised swelling may develop at the site of the injection and a firm nodular lump may persist for some weeks or even months.
Cases have been recorded of goats developing signs of anaphylactoid shock shortly after vaccination. This is believed to be due to protein sensitisation as a result of previous vaccination. This vaccine has been prepared in a manner which will reduce the risk as far as possible. Nevertheless, observe valuable animals closely for 1 hour after vaccination; obtain veterinary assistance immediately if signs of shock become evident.